1 / 7

Philip Mease

GRAPPA Group for Research and Assessment of Psoriasis and Psoriatic Arthritis EULAR 2005 Introduction. Philip Mease. GRAPPA EULAR 2005 Agenda. GRAPPA AGENDA FOR EULAR 1:00        Welcome (P. Mease) 1:00 Radiology Assessment Committee Report (D van der Heijde)

tynice
Download Presentation

Philip Mease

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. GRAPPAGroup for Research and Assessment of Psoriasis and Psoriatic ArthritisEULAR 2005Introduction Philip Mease

  2. GRAPPA EULAR 2005 Agenda GRAPPA AGENDA FOR EULAR 1:00        Welcome (P. Mease) 1:00 Radiology Assessment Committee Report (D van der Heijde) 1:30        CASPAR Update (P. Helliwell, W. Taylor) 2:15        Treatment Guidelines Update and Consensus Discussion                         (A. Kavanaugh, C. Ritchlin) 3:30 Break 3:45        Committee Reports and Feedback Measurement (D Gladman) Research Committee (P. Helliwell) QOL/Participation (P. Mease/W. Taylor) PGA/VAS (A. Cauli) Tissue Histology (D. Baeten) World Congress (PsO/PsA) in Stockholm                                     May 31-Jun 2, 2006 (P. Mease) Reporting from Dermatology (W. Henning) Publications Committee (P. Mease) 6:00           Conclusion

  3. GRAPPA 2005 Sponsors • Abbott • Amgen • Aventis • BiogenIDEC • Centocor • Novartis • Schering-Plough • Wyeth

  4. Composition of GRAPPA174 members (6/8/05) Participant Type Dermatologist Geneticist Methodologist Patient Group Radiologist Rheumatologist Other Ex-NA 37 1 8 1 4 66 1 NA 24 1 3 3 2 20 4 Total 61 2 11 4 6 86 5 TOTAL % 67% 33% 100

  5. GRAPPA Representation by Country Australia Austria Belgium Brazil Canada Czech Republic Denmark France Germany Ireland Turkey United Kingdom United States Italy Morroco Netherlands Newfoundland New Zealand Norway Spain Sweden Switzerland

  6. Examples of GRAPPA Work Projects • Classification and diagnosis of PsA (CASPAR) • Evaluation of PsA composite outcome measures • Determination of minimal clinically important difference of outcome measures in PsA • “Participation” measure • Work impact of disease • Socioeconomic impact of therapy • Patient global assessment instrument • Axial assessment • Enthesial assessment • Dactylitis assessment • Histologic and immunohistochemical assessment • PsA treatment guidelines • Annals of Rheumatic Disease supplement on PsA and psoriasis 3/05 (32 articles, derm and rheum co-authored)

  7. “Kinderkrankheiten” Smolen J 2005

More Related